AI summary not available. Read the source abstract on PubMed.
Obstetric
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Randomised, double-blind, placebo-controlled trial of 188 women undergoing elective caesarean delivery, all receiving intrathecal morphine 100 μg.
- Wound infiltration with liposomal bupivacaine plus bupivacaine hydrochloride was compared with saline placebo, alongside standardised multimodal analgesia and hydromorphone PCA.
- 48-h opioid use was lower with treatment: 12.60 mg vs 15.75 mg oral morphine equivalents (Hodges-Lehmann -3.05 mg, 95% CI -5.9 to -1.4; P = 0.002).
- Secondary outcomes also favoured treatment, including movement pain at 24 h (40 vs 50 mm) and opioid-free status at 48 h (19.1% vs 2.1%).
- Double-blinded randomized trial of 100 women after cesarean delivery (95 completed), comparing dexamethasone 8 mg with ondansetron 4 mg.
- Both groups received spinal anesthesia with morphine 150 µg and an enhanced recovery protocol with scheduled nonopioid analgesics; the main outcome was rescue medications for nausea, vomiting, pain, or pruritus over 24 hours.
- Medication use did not differ significantly: ondansetron 0.23 (95% CI 0.11-0.35) versus dexamethasone 0.40 (0.20-0.61) per patient per 24 hours; P = .337.
- Supplemental pain medication, pain scores, nausea, and pruritus scores also showed no significant differences. The authors suggest low pain scores and breakthrough pain rates may explain the lack of pain benefit seen in prior dexamethasone studies.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.